Infrequent occurrence of this unique JAK2 mutation has been reported recently in chronic myeloid leukemia (CML), acute myelocytic leukemia, and acute lymphoblastic leukemia (Jones et al., 2005). Here, JAK2 is linked to acute lymphoblastic leukemia.